Biosignatures Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Liquidation

Biosignatures General Information

Description

Developer of molecular diagnostic tests designed to identify disease biomarkers in blood for early detection and subsequent diagnosis of life-threatening diseases. The company's tests serve to discover multiple proteins based disease diagnostics using multiple proteoform monitoring and feeding the data into a machine learning software for detecting urological cancers, enabling doctors to transform healthcare and save lives across the whole world with the help of non-invasive methods of detecting diseases.

Contact Information

Website
www.biosignatures.com
Formerly Known As
Crossco (1025)
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Fourth Floor, Dean Court
  • 22 Dean Street
  • Newcastle upon Tyne NE1 1PG
  • England, United Kingdom
+44 0191
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Biotechnology
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, HealthTech, Oncology
Corporate Office
  • Fourth Floor, Dean Court
  • 22 Dean Street
  • Newcastle upon Tyne NE1 1PG
  • England, United Kingdom
+44 0191

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosignatures Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 28-May-2021 Completed Bankruptcy: Liquidation
4. Later Stage VC 07-Aug-2019 Completed Profitable
3. Later Stage VC 07-Sep-2018 Completed Profitable
2. Later Stage VC 11-Mar-2016 $405K Completed Profitable
1. Angel (individual) 19-Jul-2012 $405K $405K Completed Generating Revenue
To view Biosignatures’s complete valuation and funding history, request access »

Biosignatures Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 2,538 $0.012384 $141.95 $141.95 1x $141.95 0.6%
Ordinary 9,352 $0.012384 $34.43 $34.43 1x $34.43 2.2%
To view Biosignatures’s complete cap table history, request access »

Biosignatures Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular diagnostic tests designed to identify disease biomarkers in blood for early detection and subsequ
Diagnostic Equipment
Newcastle upon Tyne, United Kingdom
18 As of 2021

Foster City, CA
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosignatures Competitors (34)

One of Biosignatures’s 34 competitors is Adela, a Venture Capital-Backed company based in Foster City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adela Venture Capital-Backed Foster City, CA
Genefirst Venture Capital-Backed Abingdon, United Kingdom
ROCA Test Formerly VC-backed Cambridge, United Kingdom
Foundation Medicine Formerly VC-backed Boston, MA
Freenome Formerly VC-backed Brisbane, CA
You’re viewing 5 of 34 competitors. Get the full list »

Biosignatures Patents

  • 45

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • Pending

  • Expiring in next 12 mo

Biosignatures Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3134865-A1 Real-time endoscopic image enhancement Inactive 22-Apr-2014
GB-201407078-D0 Real-time endoscopic image enhancement Inactive 22-Apr-2014
GB-2525588-A Real-time endoscopic image enhancement Inactive 22-Apr-2014
US-20170046836-A1 Real-time endoscopic image enhancement Inactive 22-Apr-2014
WO-2015162409-A1 Real-time endoscopic image enhancement Inactive 22-Apr-2014 G06T5/40
To view Biosignatures’s complete patent history, request access »

Biosignatures Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Biosignatures FAQs

  • When was Biosignatures founded?

    Biosignatures was founded in 2007.

  • Where is Biosignatures headquartered?

    Biosignatures is headquartered in Newcastle upon Tyne, United Kingdom.

  • What is the size of Biosignatures?

    Biosignatures has 18 total employees.

  • What industry is Biosignatures in?

    Biosignatures’s primary industry is Diagnostic Equipment.

  • Is Biosignatures a private or public company?

    Biosignatures is a Private company.

  • What is Biosignatures’s current revenue?

    The current revenue for Biosignatures is .

  • How much funding has Biosignatures raised over time?

    Biosignatures has raised $9.6M.

  • Who are Biosignatures’s competitors?

    Adela, Genefirst, ROCA Test, Foundation Medicine, and Freenome are some of the 34 competitors of Biosignatures.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process